Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Accumulated Expenses (2016 - 2025)

Nephros (NEPH) has 13 years of Other Accumulated Expenses data on record, last reported at $53000.0 in Q4 2024.

  • For Q4 2024, Other Accumulated Expenses fell 43.62% year-over-year to $53000.0; the TTM value through Dec 2024 reached $53000.0, down 43.62%, while the annual FY2024 figure was $53000.0, 43.62% down from the prior year.
  • Other Accumulated Expenses reached $53000.0 in Q4 2024 per NEPH's latest filing, down from $94000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $94000.0 in Q4 2021 and bottomed at $26000.0 in Q4 2022.
  • Average Other Accumulated Expenses over 5 years is $66800.0, with a median of $67000.0 recorded in 2020.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 72.34% in 2022, then skyrocketed 261.54% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $67000.0 in 2020, then surged by 40.3% to $94000.0 in 2021, then tumbled by 72.34% to $26000.0 in 2022, then surged by 261.54% to $94000.0 in 2023, then plummeted by 43.62% to $53000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $53000.0 in Q4 2024, $94000.0 in Q4 2023, and $26000.0 in Q4 2022.